Marshall professor shares kidney research in China.
Article Type: Report
Subject: Antimitotic agents (Research)
Antimitotic agents (Usage)
Antimitotic agents (Health aspects)
Antineoplastic agents (Research)
Antineoplastic agents (Usage)
Antineoplastic agents (Health aspects)
Oncology, Experimental (Evaluation)
Cancer (Research)
Cancer (Evaluation)
Pub Date: 07/01/2012
Publication: Name: West Virginia Medical Journal Publisher: West Virginia State Medical Association Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2012 West Virginia State Medical Association ISSN: 0043-3284
Issue: Date: July-August, 2012 Source Volume: 108 Source Issue: 4
Topic: Event Code: 540 Executive changes & profiles; 310 Science & research; 290 Public affairs
Product: Product Code: 2834140 Anticancer Drugs; 2834146 Chemotherapeutic Drugs; 8000220 Cancer & Cell R&D NAICS Code: 325412 Pharmaceutical Preparation Manufacturing; 54171 Research and Development in the Physical, Engineering, and Life Sciences SIC Code: 2834 Pharmaceutical preparations; 8731 Commercial physical research; 8733 Noncommercial research organizations
Organization: Organization: Marshall University
Persons: Named Person: Rankin, Gary O.
Geographic: Geographic Scope: China Geographic Code: 9CHIN China
Accession Number: 310150689
Full Text: [ILLUSTRATION OMITTED]

A Marshall University professor was in Beijing in May to present his research at BIT's 5th World Cancer Congress and to meet with colleagues at a leading university.

Dr. Gary O. Rankin, professor and chairman of the Department of Pharmacology, Physiology and Toxicology at the university's Joan C. Edwards School of Medicine, spoke about his work to study how a substance found naturally in red wine can reduce some of the harmful effects of a commonly used anti-cancer drug.

According to Rankin's study conducted in cooperation with colleague Dr. Monica A. Valentovic, resveratrol, a natural component of red wine, grapes, blueberries and peanuts, can reduce toxicity to the kidney caused by the chemotherapy drug cisplatin. The work is funded by a grant from the National Institutes of Health.

"Dr. Valentovic and I are using a human kidney cell line to look into the protective effects of resveratrol," said Rankin. "We have found that the compound's powerful antioxidant properties may be important in helping to protect the kidney from cisplatin's harmful effects."

Also at the conference, Rankin helped lead a scientific session, "Cancer rehabilitation, nutrition and management of cancer related complications."

Before the meeting in Beijing, Rankin visited the School of Biosystems Engineering and Food Science at Zhejiang University in Hangzhou, China, to give a seminar about his work in the field of chemical-induced injury to the kidney.

Rankin was accompanied on the trip by Dr. Yi Charlie Chen, an associate professor of biology at Alderson-Broaddus College in Philippi.

Both Rankin and Chen are lead researchers in the West Virginia IDeA Network of Biomedical Research Excellence--a federally funded program to help build biomedical research expertise across the state. Rankin is the principal investigator of the project and Chen is on the steering committee.
Gale Copyright: Copyright 2012 Gale, Cengage Learning. All rights reserved.